Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON40605Phase 4Recruiting
Phase 4, open-label trial of sirolimus in port-wine stain (4 arms), sponsored by Erasmus MC. Primary endpoint: Percentage clearance of the treated area assessed colorimetrically. Started Aug 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON40605.